Matt Coleman

Matt Coleman is a Senior Director of U.S. Brand Strategy at Eli Lilly, where they oversee the commercialization of the Tempo platform and lead the launch of Lilly's first once-weekly basal insulin. With over 11 years of experience at the company, Matt has held various roles, including Senior Director of US Diabetes and Obesity HCP Digital Engagement Strategy and Associate Director of Jardiance US HCP Brand Marketing. Matt's expertise encompasses sales management, brand strategy, and digital engagement, particularly in diabetes and obesity care. Matt earned a degree in Kinesiology with a focus on Applied Exercise Physiology from Texas A&M University, where they also served as a student athletic trainer.